
- Mount Sinai Doctors
- Treats Adults
- Video Visit Available
- Accepting New Patients
Parissa Tabrizian, MD
Transplantation
About Me
Parissa Tabrizian, MD, MSc is a board-certified surgeon who specializes in hepatobiliary and liver transplantation at the Recanati/Miller Transplantation Institute. She is an Associate Professor of surgery at the Mount Sinai School of Medicine. Dr. Tabrizian earned her medical degree at the University of Vienna medical school and completed her general surgery residency at the Mount Sinai Medical Center in New York. She completed fellowships in surgical oncology and multiorgan transplant surgery at Mount Sinai Hospital.
In 2015, Dr. Tabrizian obtained a master’s degree in clinical research from the Icahn School of Medicine, New York.
Dr. Tabrizian performs a wide range of both open and advanced laparoscopic procedures. Her research interests include hepatocellular carcinoma (liver cancer), cholangiocarcinoma (bile duct cancer) and liver transplantation.
Language
English, French, Farsi (Persian), German
Position
PROFESSOR | Surgery
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Research Topics
Cancer, Liver, Transplantation
Clinical Focus
- Abdominal Surgery
- Benign Neoplasm
- Bile Duct Cancer
- Bile Duct Injury
- Cholecystectomy
- Cholecystitis
- Cirrhosis
- Duodenal Cancer
- Gallbladder Cancer
- Hepatic Surgery
- Jaundice
- Laparoscopy
- Liver Cancer
- Liver Mass
- Liver Transplant
- Neuroendocrine Tumors
- Pancreatic Cancer
- Pancreatic Surgery
- Portal Hypertension
- Radiofrequency Ablation
- Spleen Surgery
- Splenectomy
- Splenic Lesion / Mass
Education
MD, Medical University Of Vienna
MSc, Icahn School of Medicine
Residency, Surgery (General Surgery)
Mount Sinai Hospital
Fellowship, Surgical Oncology
Mount Sinai Hospital
Fellowship, Transplant Surgery
Mount Sinai Hospital
Certifications
American Board of Surgery
Awards
2016
IME House Staff Excellence in Teaching Award
Mount Sinai
2011
Arthur Aufses Junior Prize in Surgery/Excellence in Teaching
Mount Sinai
2002
Alpha Omega Alpha
Alpha Omega Alpha Honor Medical Society
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information. Patients with Anthem Blue Cross Blue Shield (formerly known as Empire) please click here for more information. Patients with Molina insurance should click here for more information. Mount Sinai’s contracts with Anthem and Molina expired on December 31.
- 1199 SEIU
- AETNA - Commercial
- AETNA - Medicare
- Amidacare Medicaid
- CIGNA Healthcare
- Centivo
- Elderplan
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicaid
- EmblemHealth - HIP-Medicare
- Fidelis Health Care
- HealthFirst Medicaid
- HealthFirst Medicare
- Horizon NJ
- Magnacare-Health Care
- Medicare - NJ
- Medicare - NY
- Metroplus
- Multiplan PHCS
- NJ Medicaid
- NY Medicaid
- Oscar
- Oxford - Freedom and Liberty
- United Health Care - Commercial
- United Health Care - Empire Plan
- United Health Care - Oxford Care
- United Health Care - Top Tier
- VNSNY Choice Medicare
- VNSNY Select Health Medicaid
- VillageCareMax
- WellCare Health Plan
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade. Edgar Gonzalez-Kozlova, Robert Sweeney, Igor Figueiredo, Kevin Tuballes, Sinem Ozbey, Pauline Hamon, Matthew D. Park, Giorgio Ioannou, Yohei Nose, Ruiwei Guo, Paula Restrepo, Mark Buckup, Vladimir Roudko, Clotilde Hennequin, Jessica Le Berichel, Nicholas Venturini, Laszlo Halasz, Leanna Troncoso, Alexandra Tabachnikova, Christie Chang, Amanda Reid, Haley Brown, Theodore Chin, Rafael Cabal, Raphaël Mattiuz, Shingo Eikawa, Diane Marie Del Valle, Tina Ruth Gonsalves, Nelson M. LaMarche, Hajra Jamal, Alona Lansky, Nancy Yi, Daniella Nelson, Jarod Morgenroth-Rebin, Raphael Merand, Bryan Villagomez, Darwin D’Souza, Emir Radkevich, Kai Nie, Zhihong Chen, Yasuko Tada, Hiroyoshi Nishikawa, Stephen C. Ward, Maria Isabel Fiel, Rachel Brody, Parissa Tabrizian, Ganesh Gunasekaran, Alice O. Kamphorst, Noah Cohen, Maria Curotto de Lafaille, Olivia Hapanowicz, Natalie Lucas, Kathy Wu, Nicola James, John C. Lin, Gavin Thurston, Myron Schwartz, Nathalie Fiaschi, Seunghee Kim-Schulze, Miriam Merad, Thomas U. Marron, Sacha Gnjatic. Nature Medicine
- Safety of Immune Checkpoint Inhibitors Prior to Liver Transplantation in Hepatocellular Carcinoma. L. Aceituno, C. Magyar, P. Tabrizian, R. Marino, K. Watt, D. Chascsa, G. Schnickel, V. Banz, F. Alconchel, Celia Martagon, C. Moctezuma, T. Baker, C. Nwaduru, F. J. Krendl, R. Oberhuber, L. Ruiz-Ortega, C. Demers, R. Bucur, G. O'Kane, A. Vogel, B. Mínguez, G. Sapisochin. Alimentary Pharmacology and Therapeutics
- Laparoscopic versus open liver resection in patients aged at least 80 years: Retrospective propensity score-matched cohort study. Concepción Gómez-Gavara, Zenichi Morise, Victor López-López, Christoph Kuemmerli, Daniel Esono, Kazuharu Igarashi, Kohei Mishima, Akishige Kanazawa, Shogo Tanaka, Shoji Kubo, Satoshi Nemoto, Goro Honda, Kazuteru Monden, Masaki Ueno, Yasuhito Iwao, Naoto Gotohda, Masashi Kudo, Hiroyuki Nitta, Satoshi Amano, Rafael Díaz-Nieto, Alex Gordon-Weeks, Serena Langella, Alessandro Ferrero, Yuichiro Otsuka, Hironori Kaneko, Riccardo Boetto, Umberto Cillo, Daniel D'Souza, Pablo E. Serrano, Giammauro Berardi, Marco Angrisani, Giuseppe Maria Ettorre, Parissa Tabrizian, Allen Yu, Brian K.P. Goh, Takuya Minagawa, Osamu Itano, Daisuke Asano, Minoru Tanabe, Marcello Di Martino, Elena Martín-Pérez, Simone Famularo, Elisa Paoluzzi Tomada, Guido Torzilli, Jaime Arthur Pirola Krüger, Paulo Herman, Mario Giuffrida, Ramon Charco, Mikel Gastaca, Waclaw Holowko, Stephanie Truant, Kit Man Ho, Kai Chi Cheng, Rafael José Maurette, Laura Ann Blatt, Tatiana Belda, Yuta Abe, Shuichiro Uemura, Go Wakabayashi. BJS open
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Care Provider’s Explanation
Care Provider’s Concern
Likelihood to Recommend Care Provider
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Tabrizian has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.